Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Rybelsus (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus only, not for weight loss
Many see results after one session, but some may need a few to reach their goal
.png&w=3840&q=75)
May 2025 Updates: Highmark Network Update: Utilization Management (UM) Update for Weight Loss Drugs Carriers continue to assess their standpoint surrounding coverage for GLP-1 medications to determine how Utilization Management policy may need to be structured
Week 14 begins at 0.25 mg weekly, then increases to 0.5 mg for weeks 58, followed by 1.0 mg for weeks 912, and continuing upward by 0.25 mg increments every 4 weeks until your provider determines your therapeutic target
US$ 29.18
US$ 20.88
US$ 28.67
